Tremor
TrialsCompanies

Not investment advice.

Tremor shows what changed in public records. It never tells anyone to buy or sell. Many trial edits are harmless paperwork. Data from ClinicalTrials.gov, the SEC, and the Federal Register.

PrivacyTerms

PDSB

PDS Biotechnology Corp

Tremor tracks 1 of its cancer trials.

Company-wide warning signs

These add points to every one of this company's trials.

  • Announced layoffs or restructuringSince Aug 25, 2026+6.5

Trials

  • PDSBPDS Biotechnology Corp.
    16Calm

    Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC

    FinishedPhase 295 patientsMain results: May 14, 2025

Key executives leaving

From the last 12 months of the company's SEC reports.

None found.

Insider trades (last 6 months)

“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.

0 sales (0 not pre-planned) · 0 purchases

No insider sales or purchases in the last 6 months.

Recent SEC filings

Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.

  • Other newsNews report (8-K)Oct 21, 2026
  • An executive or board member joined or left; Other newsNews report (8-K)Oct 20, 2026
  • Permission to sell new sharesPermission to sell new shares (S-3)Oct 14, 2026
  • Other newsNews report (8-K)Oct 6, 2026
  • Other newsNews report (8-K)Sep 22, 2026

Money left

Coming soon: how many months of cash the company has, from its quarterly reports.
Other newsNews report (8-K)
Sep 21, 2026
  • Ended a major agreement; An executive or board member joined or left; Shared information with investors; Other newsNews report (8-K)Sep 14, 2026
  • Signed a major agreement; Shared information with investorsNews report (8-K)Sep 8, 2026
  • Signed a major agreementNews report (8-K)Sep 4, 2026
  • Layoffs or restructuring costs; An executive or board member joined or leftNews report (8-K)Aug 25, 2026
  • An executive or board member joined or leftNews report (8-K)Aug 19, 2026
  • News reportNews report (8-K)Aug 14, 2026
  • Quarterly reportQuarterly report (10-Q)Aug 13, 2026
  • Shared quarterly resultsNews report (8-K)Aug 13, 2026
  • Shared information with investorsNews report (8-K)Aug 11, 2026
  • Warning about being removed from the stock exchangeNews report (8-K)Jul 31, 2026
  • Permission to sell new sharesPermission to sell new shares (S-3)Jul 10, 2026
  • New shares being soldNew shares being sold (424B5)Jun 15, 2026
  • Signed a major agreement; Ended a major agreementNews report (8-K)Jun 15, 2026
  • Other newsNews report (8-K)Jun 15, 2026
  • Other newsNews report (8-K)Jun 2, 2026
  • Quarterly reportQuarterly report (10-Q)May 14, 2026
  • Shared quarterly resultsNews report (8-K)May 13, 2026